Correlation Between Equinox Chesapeake and Blackrock Health

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Equinox Chesapeake and Blackrock Health at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Equinox Chesapeake and Blackrock Health into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Equinox Chesapeake Strategy and Blackrock Health Sciences, you can compare the effects of market volatilities on Equinox Chesapeake and Blackrock Health and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Equinox Chesapeake with a short position of Blackrock Health. Check out your portfolio center. Please also check ongoing floating volatility patterns of Equinox Chesapeake and Blackrock Health.

Diversification Opportunities for Equinox Chesapeake and Blackrock Health

0.21
  Correlation Coefficient

Modest diversification

The 3 months correlation between Equinox and Blackrock is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding Equinox Chesapeake Strategy and Blackrock Health Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Blackrock Health Sciences and Equinox Chesapeake is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Equinox Chesapeake Strategy are associated (or correlated) with Blackrock Health. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Blackrock Health Sciences has no effect on the direction of Equinox Chesapeake i.e., Equinox Chesapeake and Blackrock Health go up and down completely randomly.

Pair Corralation between Equinox Chesapeake and Blackrock Health

Assuming the 90 days horizon Equinox Chesapeake Strategy is expected to under-perform the Blackrock Health. But the mutual fund apears to be less risky and, when comparing its historical volatility, Equinox Chesapeake Strategy is 1.08 times less risky than Blackrock Health. The mutual fund trades about -0.03 of its potential returns per unit of risk. The Blackrock Health Sciences is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest  6,344  in Blackrock Health Sciences on September 23, 2024 and sell it today you would lose (305.00) from holding Blackrock Health Sciences or give up 4.81% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Equinox Chesapeake Strategy  vs.  Blackrock Health Sciences

 Performance 
       Timeline  
Equinox Chesapeake 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Equinox Chesapeake Strategy has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong basic indicators, Equinox Chesapeake is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Blackrock Health Sciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Blackrock Health Sciences has generated negative risk-adjusted returns adding no value to fund investors. In spite of weak performance in the last few months, the Fund's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the fund investors.

Equinox Chesapeake and Blackrock Health Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Equinox Chesapeake and Blackrock Health

The main advantage of trading using opposite Equinox Chesapeake and Blackrock Health positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Equinox Chesapeake position performs unexpectedly, Blackrock Health can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Blackrock Health will offset losses from the drop in Blackrock Health's long position.
The idea behind Equinox Chesapeake Strategy and Blackrock Health Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Complementary Tools

Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets